Protein kinase C (PKC) is a serine/threonine kinase belonging to the AGC family. PKC isoenzymes are activated by phospholipid-derived second messengers, transmit their signal by phosphorylating specific substrates and play a pivotal role in the regulation of various cell functions, including metabolism, growth, differentiation and apoptosis. Therefore they represent an interesting molecular target for the treatment of several diseases, such as cancer and Alzheimer's disease. Adopting a structure-based approach on the crystal structure of the PKCδ C1B domain, our team has developed isophthalic acid derivatives that are able to modify PKC functions by binding to the C1 domain of the enzyme. Bis[3-(trifluoromethyl)benzyl] 5-(hydroxymethyl)isophthalate (HMI-1a3) and bis(1-ethylpentyl) 5-(hydroxymethyl)isophthalate (HMI-1b11) were selected from a set of compounds for further studies due to their high affinity for the C1 domains of PKCα and PKCδ. HMI-1a3 showed marked antiproliferative activity in HeLa cells whereas HMI-1b11 induced differentiation and supported neurite growth in SH-SY5Y cells. Our aim in the future is to improve the selectivity and potency of isophthalate derivatives, to clarify their mechanism of action in the cellular environment and to assess their efficacy in cell-based and in vivo disease models. HMI-1a3 has already been selected for a further project and redesigned to function as a probe immobilized on an affinity chromatography column. It will be used to identify cellular target proteins from cell lysates, providing new insights into the mechanism of action of HMI-1a3.
Skip Nav Destination
Article navigation
December 2014
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
November 17 2014
C1 domain-targeted isophthalates as protein kinase C modulators: structure-based design, structure–activity relationships and biological activities
Virpi Talman;
Virpi Talman
1
*Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, 00014 Helsinki, Finland
1To whom correspondence should be addressed (emailvirpi.talman@helsinki.fi).
Search for other works by this author on:
Riccardo Provenzani;
Riccardo Provenzani
†Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, 00014 Helsinki, Finland
Search for other works by this author on:
Gustav Boije af Gennäs;
Gustav Boije af Gennäs
†Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, 00014 Helsinki, Finland
Search for other works by this author on:
Raimo K. Tuominen;
Raimo K. Tuominen
*Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, 00014 Helsinki, Finland
Search for other works by this author on:
Jari Yli-Kauhaluoma
Jari Yli-Kauhaluoma
†Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, 00014 Helsinki, Finland
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
July 02 2014
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© The Authors Journal compilation © 2014 Biochemical Society
2014
Biochem Soc Trans (2014) 42 (6): 1543–1549.
Article history
Received:
July 02 2014
Citation
Virpi Talman, Riccardo Provenzani, Gustav Boije af Gennäs, Raimo K. Tuominen, Jari Yli-Kauhaluoma; C1 domain-targeted isophthalates as protein kinase C modulators: structure-based design, structure–activity relationships and biological activities. Biochem Soc Trans 1 December 2014; 42 (6): 1543–1549. doi: https://doi.org/10.1042/BST20140181
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.